Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 2000

View Archived Issues

Carvedilol surpasses metoprolol in long-term heart failure treatment

EPTTCO and Onyx establish agreement for anticancer agents

Etanercept is well tolerated and efficacious as psoriatic arthritis and psoriasis treatment

Secretin studies in autism reported at pediatric gastroenterology conference

Showa Yakuhin to market CollaGenex's Periostat in Japan

Vion receives NCI research contract to explore TAPET in tumor imaging

Biomira initiates phase IIb trial of BLP25 vaccine

Protein implicated in Ebola virus toxicity

Spherons potentially linked to Alzheimer's disease

Retinoid supplementation improves mouse model of childhood blindness

Mice bred to develop neurofibrillary tangles for dementia research

Access to Kaletra early access program expanded for HIV patients

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Glutamate/serotonin interactions in prefrontal cortex explored

Maxim and Roche to develop combination therapy for hepatitis C and cancer

Theratechnologies to begin PDT trial in Canada

Elan and Pharmacia to collaborate on developing beta-secretase inhibitors

New compounds at Aventis show activity against Gram-positive bacteria

Factor Xa inhibitors under study at Aventis useful for thromboembolic diseases

Tachykinin antagonists discovered at Nippon Zoki

Novel isochroman compound useful for Alzheimer's disease

Janssen receives patent for new antihistaminic series

New compounds interacting with 5-HT6 receptors under development at Merck KGaA

New farnesyl protein transferase inhibitors useful for various tumors

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...